Clinical Trial Update: A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the long-term safety of finerenone in children aged 1 to 18 with chronic kidney disease and proteinuria, when used with a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Proteinuria

Drugs mentioned

• Finerenone (Kerendia) (finerenone)

Snippet

Sponsor: Bayer | Conditions: Chronic Kidney Disease, Proteinuria | Phase 3 | Status: RECRUITING